SCHEMBL7380955

SCHEMBL7380955

Cc1cc2cnccc2[nH]c1=O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 2/20 0.65
BRD4 O60885 1/20 0.58
PDE3B Q13370 1/20 0.53
PDE3A Q14432 1/20 0.53
ATAD2 Q6PL18 1/20 0.47
PARP1 P09874 3/20 0.45
HRH4 Q9H3N8 1/20 0.43
MAPT P10636 1/20 0.42
SNCA P37840 1/20 0.42
CLK2 P49760 1/20 0.41
CLK3 P49761 1/20 0.41
DYRK1A Q13627 1/20 0.41
ACHE P22303 1/20 0.41
GRIN2D O15399 1/20 0.41
GRIN3B O60391 1/20 0.41
GRIN1 Q05586 1/20 0.41
GRIN2A Q12879 1/20 0.41
GRIN2B Q13224 1/20 0.41
GRIN2C Q14957 1/20 0.41
GRIN3A Q8TCU5 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15906825 0.86 DAO (0.65) DAOBRD4PDE3BPDE3AATAD2
SCHEMBL8146950 0.80 DAO (0.54) DAOBRD4PDE3BPDE3APARP1
SCHEMBL24312093 0.79 DAO (0.61) DAOPDE3BPDE3APARP1HRH4
SCHEMBL21957317 0.79 DAO (0.65) DAOPDE3BPDE3APARP1HRH4
SCHEMBL31475468 0.79 DAO (0.65) DAOPDE3BPDE3APARP1HRH4
SCHEMBL3360519 0.79 DAO (1.00) DAOPDE3BPDE3APARP1HRH4
SCHEMBL22016192 0.78 DAO (0.59) DAOPDE3BPDE3APARP1HRH4
SCHEMBL22017082 0.78 DAO (0.59) DAOPDE3BPDE3APARP1HRH4
SCHEMBL3359700 0.78 DAO (0.59) DAOPDE3BPDE3APARP1HRH4
SCHEMBL4310842 0.78 DAO (0.59) DAOPDE3BPDE3APARP1HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0134535-B1 1,6-NAPHTHYRIDIN DERIVATIVES USEFUL AS CARDIOTONICS AND PREPARATION THEREOF STERLING DRUG INC. (US) 1988-10-26 EP disclosed
EP-0101952-B1 5-ALKYL-1,6-NAPHTHYRIDIN-2(1H)-ONES, INTERMEDIATES, THEIR PREPARATION AND THEIR CARDIOTONIC USE STERLING DRUG INC. (US) 1987-09-23 EP disclosed
EP-0204335-A2 2(1H)-Pyridin-ones useful as intermediates STERLING DRUG INC. (US) 1986-12-10 EP disclosed
US-4604399-A 5-methyl(or ethyl)-1,6-naphthyridin-2(1H)-one 6-oxides, their preparation and the cardiotonic use thereof STERLING DRUG INC. (US) 1986-08-05 US disclosed
US-4559347-A 3-Substituted-5-alkyl-1,6-naphthyridin-2(1H)-ones, cardiotonic use and preparation thereof STERLING DRUG INC. (US) 1985-12-17 US disclosed
US-4532247-A Increases cardiac contractility STERLING DRUG INC. (US) 1985-07-30 US disclosed
US-4517190-A 5-Alkyl-1,6-naphthyridin-2(1H)-ones and cardiotonic use thereof STERLING DRUG INC. (US) 1985-05-14 US disclosed
EP-0134535-A1 1,6-Naphthyridin derivatives useful as cardiotonics and preparation thereof STERLING DRUG INC. (US) 1985-03-20 EP disclosed
EP-0101952-A1 5-Alkyl-1,6-naphthyridin-2(1H)-ones, intermediates, their preparation and their cardiotonic use STERLING DRUG INC. (US) 1984-03-07 EP disclosed
US-4415580-A Certain 2-(1H)-pyridinones cardiotonic compositions containing same and method of using same STERLING DRUG INC. (US) 1983-11-15 US disclosed